Vol. 9 No. 4
February/March 2007

Return to Contents

Drugs and Money
Pharmaceutical companies, academic medicine, and the flow of funds and favors

Reviewing conflict-of-interest policies

Funds flowing in

"We accept money because we need to do clinical trials, and that's where the rubber meets the road in this conflict-of-interest business."

"I'm not under any illusion that [drug companies] give money for the sake of neuroscience. They won't do a study if the potential is there for the outcome to have a negative impact on marketing."

Bringing the Big Questions to the Community
Re-imagining the Gustafson Seminar

Multiversity or University?
Pursuing competing goods simultaneously

Uprooted
On the failure of roots and the strength of weak ties

Endnotes

Each year, the Office of Research Administration issues a report detailing the amount of money awarded to Emory from organizations outside of the university. The following are some key statistics from the report for Fiscal Year 2006.